◼ Archived
Business
🔮 holds ✗
GSK catches phase 3 fever after mRNA flu vaccine beats standard shots
GSK's mRNA flu vaccine is advancing to Phase 3 trials after outperforming standard shots in Phase 2.
Flu Vaccine
10 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Flu Vaccine
This hub groups 10 separate news trends connected to Flu Vaccine, spanning June 19, 2026 through September 1, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 91 article observations and 88 source signals, led by Business, Health coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Health
🔮 fades ✓
You Can Get Your Flu Shot Right Now, Despite The Government's Radio Silence
Flu shots are available now, even as federal guidance remains unclear.
◼ Archived
Health
🔮 fades ✓
Your guide to fall 2026 vaccines
Fall 2026 brings a complex vaccine landscape, with flu shots available but COVID-19 vaccines delayed.
◼ Archived
Health
🔮 fades ✓
As the school year begins, here's what to know about flu, COVID shots
As schools reopen this August, health officials flood communities with flu and COVID vaccine guidance for students.
◼ Archived
Business
🔮 fades ✓
There’s a new type of flu vaccine for older adults this year. Can you get it?
A new mRNA flu vaccine for older adults has been approved, but availability remains uncertain.
◼ Archived
Health
🔮 fades ✓
Covid-19 and dengue creeping up, vaccinations creeping down, a new mRNA flu vaccine, and more
Vaccination rates are dropping as Covid-19 and dengue cases rise, and a new mRNA flu vaccine is on the horizon.
◼ Archived
Business
🔮 holds ✗
F.D.A. Approves Moderna’s mRNA Flu Vaccine
The FDA's approval of Moderna's mRNA flu vaccine marks a significant shift in seasonal flu prevention, particularly for older adults.
◼ Archived
Health
🔮 fades ✓
FDA approves 1st mRNA flu shot, from Moderna
The FDA has approved the first mRNA flu vaccine, marking a significant shift in flu shot technology.
◼ Archived
Business
🔮 fades ✓
Sanofi under antitrust probe as European Commission kicks off formal proceedings
The European Commission has launched a formal antitrust investigation into Sanofi's flu vaccine marketing campaigns.
◼ Archived
Business
🔮 fades ✓
New First-of-Its-Kind Flu Vaccine Approved by FDA Expert Panel
An FDA advisory panel has unanimously endorsed Moderna's first-of-its-kind mRNA-based seasonal influenza vaccine, mRNA-1010.